These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1988235)

  • 21. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An alternative test for acetylator phenotyping with caffeine.
    Tang BK; Kadar D; Kalow W
    Clin Pharmacol Ther; 1987 Nov; 42(5):509-13. PubMed ID: 3677540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical issues in the management of hypersensitivity reactions: sulfonamides.
    Tilles SA
    South Med J; 2001 Aug; 94(8):817-24. PubMed ID: 11549195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylator variability in Down's syndrome: characterization with caffeine.
    Morris ME; Griener JC; Msall ME
    Clin Pharmacol Ther; 1989 Sep; 46(3):359-66. PubMed ID: 2528436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.
    Kaufmann GR; Wenk M; Taeschner W; Peterli B; Gyr K; Meyer UA; Haefeli WE
    Clin Pharmacol Ther; 1996 Jul; 60(1):62-7. PubMed ID: 8689813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylation polymorphism of caffeine in a Japanese population.
    Hashiguchi M; Ebihara A
    Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
    Ellard GA; Gammon PT
    Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins.
    Cribb AE; Pohl LR; Spielberg SP; Leeder JS
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1064-71. PubMed ID: 9262376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
    Cui X; Guo R; Xu Z; Wang B; Li C
    Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides.
    Gupta A; Eggo MC; Uetrecht JP; Cribb AE; Daneman D; Rieder MJ; Shear NH; Cannon M; Spielberg SP
    Clin Pharmacol Ther; 1992 Jan; 51(1):56-67. PubMed ID: 1732077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients.
    Deloménie C; Grant DM; Mathelier-Fusade P; Jacomet C; Leynadier F; Jacqz-Aigrain E; Rozenbaum W; Krishnamoorthy R; Dupret JM
    Br J Clin Pharmacol; 1994 Dec; 38(6):581-2. PubMed ID: 7888297
    [No Abstract]   [Full Text] [Related]  

  • 37. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
    Agúndez JA; Carrillo JA; Martínez C; Benítez J
    Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetyl-transferase phenotype and risk for preeclampsia.
    Zusterzeel PL; te Morsche RH; Raijmakers MT; Roes EM; Peters WH; Steegers-Theunissen RP; Steegers EA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):797-802. PubMed ID: 16150277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphic acetylation of hydralazine.
    Timbrell JA; Harland SJ; Facchini V
    Clin Pharmacol Ther; 1980 Sep; 28(3):350-5. PubMed ID: 7408395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.